Christopher R. Fenimore - 31 Mar 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Controller
Signature
/s/**Christopher R. Fenimore
Issuer symbol
REGN
Transactions as of
31 Mar 2022
Net transactions value
-$2,250,727
Form type
4
Filing time
01 Apr 2022, 16:07:40 UTC
Previous filing
14 Dec 2021
Next filing
11 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $1,111,340 +2,000 +9.3% $555.67 23,425 31 Mar 2022 Direct
transaction REGN Common Stock Tax liability $1,259,679 -1,797 -7.7% $700.99 21,628 31 Mar 2022 Direct
transaction REGN Common Stock Options Exercise $2,704,300 +10,000 +46% $270.43 31,628 31 Mar 2022 Direct
transaction REGN Common Stock Tax liability $4,806,688 -6,857 -22% $700.99 24,771 31 Mar 2022 Direct
holding REGN Common Stock 1,779 31 Mar 2022 2021 GRAT
holding REGN Common Stock 1,459 31 Mar 2022 By 401(k) Plan
holding REGN Common Stock 1,897 31 Mar 2022 By Trust F1
holding REGN Common Stock 1,348 31 Mar 2022 by 2018 GRAT
holding REGN Common Stock 25 31 Mar 2022 by Trust for Daugh
holding REGN Common Stock 25 31 Mar 2022 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10,000 -50% $0.000000 10,000 31 Mar 2022 Common Stock 10,000 $270.43 Direct F2
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,000 -14% $0.000000 12,450 31 Mar 2022 Common Stock 2,000 $555.67 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.